# To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

> **NCT06221020** · — · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Enhanced Recovery After Surgery
- Pituitary Tumor
- Postoperative Complications

## Interventions

- **DIAGNOSTIC_TEST:** Malnutrition Universal Screening Tool
- **DEVICE:** TIB Olfactory Test Device
- **DIAGNOSTIC_TEST:** Apfel Score for Postoperative nausea and vomiting
- **DIAGNOSTIC_TEST:** The American Society of Anesthesiologists (ASA) Physical Status Classification
- **BEHAVIORAL:** Short Form-36
- **BEHAVIORAL:** World Health Organization Quality of Life questionnaire (WHOQOL-BREF)
- **BEHAVIORAL:** BDI-II(Beck Depression Inventory-II)
- **BEHAVIORAL:** ERAS Patient Satisfaction Questionnaire(ERAS-PSQ)
- **BEHAVIORAL:** Quality of Recovery-40(QoR-40)

## Key facts

- **NCT ID:** NCT06221020
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-12
- **Primary completion:** 2024-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06221020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06221020, "To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06221020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*